Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Feb;105(2):381–387. doi: 10.1111/j.1476-5381.1992.tb14262.x

Characterization of postsynaptic alpha-adrenoceptors in the arteries supplying the oviduct.

G Costa 1, M Isla 1, A García-Pascual 1, E Jimenez 1, P Recio 1, A Labadia 1, A García-Sacristán 1
PMCID: PMC1908651  PMID: 1348445

Abstract

1. In vitro experiments were designed to characterize postjunctional alpha-adrenoceptor subtypes in ring segments (1 mm length; outer diameter 300-500 microns) from arteries supplying the oviduct of the heifer. 2. Noradrenaline, adrenaline and phenylephrine evoked concentration-dependent contractile responses. The pD2 values were 5.67, 5.89 and 5.93, respectively. Medetomidine clonidine and B-HT 920 (2-amino-6-allyl-5,6,7,8-tetra-hydro-4H-(thiazo)-4,5-d-azepoine ) were ineffective. 3. The alpha-adrenoceptor selective antagonists, prazosin (1 nM-0.1 microM) and rauwolscine (0.1-10 microM) competitively antagonized the response to noradrenaline. The pA2 values were 9.38 and 6.83, respectively. 4. The dissociation constant (KD) for noradrenaline calculated by use of the irreversible antagonist, dibenamine, was 3.95 (2.09-5.81) microM. The occupancy-response relationship was non-linear. Half-maximal response to noradrenaline was obtained with 22% receptor occupancy while maximal response required 100% occupancy. 5. B-HT 920 evoked a biphasic contractile concentration-dependent response in preparations incubated in a physiological solution containing 20 mM K+, 0.1 microM prazosin and 1 microM propranolol. Rauwolscine 0.1 microM significantly (P less than 0.01) blocked the first component of the B-HT 920 concentration-response curve with an apparent pA2 value of 8.52 (7.86-9.18). 6. These results strongly suggest that alpha-adrenoceptors in oviductal arteries are mainly of the alpha 1 subtype, although a possible role for alpha 2-adrenoceptors cannot be excluded.

Full text

PDF
381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agrawal D. K., Triggle C. R., Daniel E. E. Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds. J Pharmacol Exp Ther. 1984 Jun;229(3):831–838. [PubMed] [Google Scholar]
  3. Andersson K. E., Larsson B., Sjögren C. Characterization of the alpha-adrenoceptors in the female rabbit urethra. Br J Pharmacol. 1984 Feb;81(2):293–300. doi: 10.1111/j.1476-5381.1984.tb10078.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bevan J. A. A comparison of the contractile responses of the rabbit basilar and pulmonary arteries to sympathomimetic agonists: further evidence for variation in vascular adrenoceptor characteristics. J Pharmacol Exp Ther. 1981 Jan;216(1):83–89. [PubMed] [Google Scholar]
  5. Brundin J., Fredricsson B., Norberg K. A., Swedin G. The sympathetic innervation of the oviduct in the rat. Acta Physiol Scand. 1969 Jan-Feb;75(1):69–72. doi: 10.1111/j.1748-1716.1969.tb04356.x. [DOI] [PubMed] [Google Scholar]
  6. Cavero I., Shepperson N., Lefèvre-Borg F., Langer S. Z. Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha 2-adrenoceptor agonists by diltiazem and verapamil. Circ Res. 1983 Feb;52(2 Pt 2):I69–I76. [PubMed] [Google Scholar]
  7. Fallgren B., Edvinsson L. Characterization of adrenoceptor mechanisms in isolated guinea-pig uterine arteries. Eur J Pharmacol. 1986 Nov 19;131(2-3):163–170. doi: 10.1016/0014-2999(86)90569-8. [DOI] [PubMed] [Google Scholar]
  8. Forman A., Andersson K. E., Maigaard S. Effects of calcium channel blockers on the female genital tract. Acta Pharmacol Toxicol (Copenh) 1986;58 (Suppl 2):183–192. doi: 10.1111/j.1600-0773.1986.tb02535.x. [DOI] [PubMed] [Google Scholar]
  9. Forman A., Andersson K. E., Maigaard S., Ulmsten U. Concentrations and contractile effects of substance P in the human ampullary-isthmic junction. Acta Physiol Scand. 1985 May;124(1):17–23. doi: 10.1111/j.1748-1716.1985.tb07627.x. [DOI] [PubMed] [Google Scholar]
  10. Furuta T. Precontraction-induced contractile response of isolated canine portal vein to alpha-2 adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):525–530. doi: 10.1007/BF00182726. [DOI] [PubMed] [Google Scholar]
  11. Harker C. T., Ousley P. J., Harris E. J., Edwards J. M., Taylor L. M., Porter J. M. The effects of cooling on human saphenous vein reactivity to adrenergic agonists. J Vasc Surg. 1990 Jul;12(1):45–49. doi: 10.1067/mva.1990.20311. [DOI] [PubMed] [Google Scholar]
  12. Howe G. R., Black D. L. Autonomic nervous system and oviduct function in the rabbit. I. Hormones and contraction. J Reprod Fertil. 1973 Jun;33(3):425–430. doi: 10.1530/jrf.0.0330425. [DOI] [PubMed] [Google Scholar]
  13. Högestätt E. D., Andersson K. E., Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 1983 Jan;117(1):49–61. doi: 10.1111/j.1748-1716.1983.tb07178.x. [DOI] [PubMed] [Google Scholar]
  14. Högestätt E. D., Andersson K. E. On the postjunctional alpha-adrenoreceptors in rat cerebral and mesenteric arteries. J Auton Pharmacol. 1984 Sep;4(3):161–173. doi: 10.1111/j.1474-8673.1984.tb00093.x. [DOI] [PubMed] [Google Scholar]
  15. Isla M., Costa G., García-Pascual A., Triguero D., García-Sacristán A. Intrinsic spontaneous activity and beta-adrenoceptor-mediated tubal dilatation affect ovum transport in the oviduct of the cow. J Reprod Fertil. 1989 Jan;85(1):79–87. doi: 10.1530/jrf.0.0850079. [DOI] [PubMed] [Google Scholar]
  16. Isla M., Dyer D. C. Characterization of alpha-adrenoceptors in the late pregnant ovine uterine artery. Eur J Pharmacol. 1990 Mar 27;178(3):321–331. doi: 10.1016/0014-2999(90)90111-i. [DOI] [PubMed] [Google Scholar]
  17. Juorio A. V., Chedrese P. J., Li X. M. The influence of ovarian hormones on the rat oviductal and uterine concentration of noradrenaline and 5-hydroxytryptamine. Neurochem Res. 1989 Sep;14(9):821–827. doi: 10.1007/BF00964810. [DOI] [PubMed] [Google Scholar]
  18. Kenakin T. P. The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev. 1984 Sep;36(3):165–222. [PubMed] [Google Scholar]
  19. Leese H. J. The formation and function of oviduct fluid. J Reprod Fertil. 1988 Mar;82(2):843–856. doi: 10.1530/jrf.0.0820843. [DOI] [PubMed] [Google Scholar]
  20. MacLean M. R., McGrath J. C. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1990 Sep;101(1):205–211. doi: 10.1111/j.1476-5381.1990.tb12114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Oriowo M. A., Bevan J. A., Bevan R. D. Variation in sensitivity of six cat and six rat arteries to norepinephrine can be related to differences in agonist affinity and receptor reserve. J Pharmacol Exp Ther. 1989 Oct;251(1):16–20. [PubMed] [Google Scholar]
  22. Rodriguez-Martinez H. Effects of adrenergic agents on the in vitro motility of porcine oviducts. Zentralbl Veterinarmed A. 1984 Mar;31(2):91–104. doi: 10.1111/j.1439-0442.1984.tb01265.x. [DOI] [PubMed] [Google Scholar]
  23. Ruffolo R. R., Jr Review important concepts of receptor theory. J Auton Pharmacol. 1982 Dec;2(4):277–295. doi: 10.1111/j.1474-8673.1982.tb00520.x. [DOI] [PubMed] [Google Scholar]
  24. Samuelson U. E., Sjöstrand N. O. Myogenic and neurogenic control of electrical and mechanical activity in human oviductal smooth muscle. Acta Physiol Scand. 1986 Mar;126(3):355–363. doi: 10.1111/j.1748-1716.1986.tb07827.x. [DOI] [PubMed] [Google Scholar]
  25. Scheinin M., Kallio A., Koulu M., Viikari J., Scheinin H. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers. Br J Clin Pharmacol. 1987 Oct;24(4):443–451. doi: 10.1111/j.1365-2125.1987.tb03196.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Starke K. Alpha-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol. 1981;88:199–236. [PubMed] [Google Scholar]
  27. Starke K., Docherty J. R. Types and functions of peripheral alpha-adrenoceptors. J Cardiovasc Pharmacol. 1982;4 (Suppl 1):S3–S7. doi: 10.1097/00005344-198200041-00002. [DOI] [PubMed] [Google Scholar]
  28. Sulpizio A., Hieble J. P. Demonstration of alpha 2-adrenoceptor-mediated contraction in the isolated canine saphenous artery treated with Bay K 8644. Eur J Pharmacol. 1987 Mar 3;135(1):107–110. doi: 10.1016/0014-2999(87)90765-5. [DOI] [PubMed] [Google Scholar]
  29. Templeton A. G., Macmillan J., McGrath J. C., Storey N. D., Wilson V. G. Evidence for prazosin-resistant, rauwolscine-sensitive alpha-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1989 Jun;97(2):563–571. doi: 10.1111/j.1476-5381.1989.tb11986.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Timmermans P. B., van Zwieten P. A. Mini-review. The postsynaptic alpha 2-adrenoreceptor. J Auton Pharmacol. 1981 Mar;1(2):171–183. doi: 10.1111/j.1474-8673.1981.tb00509.x. [DOI] [PubMed] [Google Scholar]
  31. Timmermans P. B., van Zwieten P. A. alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. J Med Chem. 1982 Dec;25(12):1389–1401. doi: 10.1021/jm00354a001. [DOI] [PubMed] [Google Scholar]
  32. VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
  33. van Zwieten P. A., Timmermans P. B. Alpha-adrenoceptor stimulation and calcium movements. Blood Vessels. 1987;24(5):271–280. doi: 10.1159/000158703. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES